OTR Therapeutics and Zealand Pharma collaborate to develop novel metabolic disease treatments, with a potential deal value of ...

PE: How will recent regulatory developments at FDA impact feasibility assessments in clinical planning? Woollett: It’s ...

While pharmaceutical pricing has been a controversial topic for many years, a new spotlight was shone on it over the past 12 months.

In today’s Pharmaceutical Executive Daily, the FDA introduces a new superiority standard for future CAR-T approvals, Relation ...

Fondazione Telethon announced that FDA has approved its Biologics License Application (BLA) for Waskyra (etuvetidigene ...

Several high-quality systemic reviews also found that pharmacist- and nurse-led interventions—such as patient education, ...

With only 11% of organizations reporting comprehensively organized and accessible data for AI applications, data readiness ...

The collaboration agreement joins Relation’s AI-powered drug discovery platform and human data generation capabilities with ...

How pharma marketers can time brand messages to prescribers when it matters most.

Pfizer announced it has entered into an exclusive global collaboration and license agreement with Chongqing Yao ...

Early real-world findings show that Carvykti, a BCMA-directed CAR T-cell therapy, is demonstrating sustained remissions in ...

Jaypirca is approved for the treatment of adults with relapsed or refractory CLL/SLL who were previously treated with a ...